The U.S. Food and Drug Administration (FDA) has lifted its partial hold on clinical trials of OAV-101 (AVXS-101), an investigational intrathecal gene therapy for the
Originally published as FDA Lifts Hold on Clinical Trials of Intrathecal OAV-101 at SMA News Today
Keep up with news like this
If you find resources like this helpful, consider subscribing to our newsletter so you can have the latest news, analyses, podcasts, and videos mailed to you.
We'd really like to hear what you think about any of the articles we share here, our site, or anything we can do to be more useful for you. Thank you!